Trial Watch: Toll-like receptor agonists for cancer therapy

Toll-like receptors (TLRs) have long been known for their ability to initiate innate immune responses upon exposure to conserved microbial components such as lipopolysaccharide (LPS) and double-stranded RNA. More recently, this family of pattern recognition receptors has been attributed a critical r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Vacchelli, Erika, Eggermont, Alexander, Sautès-Fridman, Catherine, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Landes Bioscience 2013
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782517/
https://ncbi.nlm.nih.gov/pubmed/24083080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.25238
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak